article Open AccessTop 1% cited

Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019

Clinical Infectious Diseases · 2020 · Vol. 71(16) · pp. 2027–2034

Juanjuan Zhao✉(Shenzhen Third People’s Hospital)Quan Yuan(Xiamen University)Haiyan Wang(Shenzhen Third People’s Hospital)Wei Liu(Xiamen University)Xuejiao Liao(Shenzhen Third People’s Hospital)Yingying Su(Xiamen University)Xin Wang(Shenzhen Third People’s Hospital)Jing Yuan(Shenzhen Third People’s Hospital)Tingdong Li(Xiamen University)Jinxiu Li(Shenzhen Third People’s Hospital)Shen Qian(Shenzhen Third People’s Hospital)Congming Hong(Xiamen University)Fuxiang Wang(Shenzhen Third People’s Hospital)Yingxia Liu(Southern University of Science and Technology)Zhaoqin Wang(Southern University of Science and Technology)Qing He(Southern University of Science and Technology)Zhiyong Li(Xiamen University)Bin He(Xiamen University)Tianying Zhang(Xiamen University)Yang Fu(Southern University of Science and Technology)Shengxiang Ge(Xiamen University)Lei Liu(Southern University of Science and Technology)Jun Zhang(Xiamen University)Ningshao Xia(Xiamen University)Zheng Zhang(Southern University of Science and Technology)

View via DOI Full-text PDF

Abstract

Antibody detection offers vital clinical information during the course of SARS-CoV-2 infection. The findings provide strong empirical support for the routine application of serological testing in the diagnosis and management of COVID-19 patients.

SARS-CoV-2 and COVID-19 Research COVID-19 Clinical Research Studies SARS-CoV-2 detection and testingSeroconversionMedicineAntibodyTiterImmunologyImmunoglobulin MSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)CoronavirusSerology

MeSH terms

COVID-19SARS-CoV-2AdultAgedAntibodies, ViralAntibody FormationEnzyme-Linked Immunosorbent AssayFemaleHumansImmunoglobulin GImmunoglobulin MMaleMiddle AgedSerologic TestsPandemics